Cytek Biosciences Executive and Leadership Team

Wenbin Jiang, the Chief Executive Officer & Chairman at Cytek Biosciences, directs the company's overarching strategy and corporate governance. Jiang guides the organization's vision, ensuring alignment with its mission to develop advanced cell analysis tools. This leadership role involves setting strategic priorities for research and development, particularly concerning the patented Full Spectrum Profiling technology. Jiang oversees the expansion of Cytek's product portfolio, including the Aurora and Northern Lights systems, and their integration into scientific research institutions and laboratories worldwide. The Chief Executive Officer & Chairman also champions the company's market position within the biotechnology and scientific research services sector. By fostering innovation and driving operational excellence, Wenbin Jiang ensures Cytek Biosciences maintains its leadership in high-resolution, high-sensitivity cell analysis solutions across North America, Europe, and Asia.

William McCombe, the Chief Financial Officer at Cytek Biosciences, manages all financial operations and fiscal strategy. McCombe oversees budgeting, forecasting, and financial reporting, ensuring the company's fiscal health and sustainable growth. This role involves managing capital allocation, investor relations, and financial risk assessment across global operations in North America, Europe, and Asia. The Chief Financial Officer plays a critical part in supporting the company's research and development initiatives, particularly those related to its patented Full Spectrum Profiling technology. McCombe ensures that financial resources are effectively deployed to enhance the development and distribution of scientific instruments like the Aurora and Northern Lights systems. By maintaining robust financial controls and driving financial efficiency, William McCombe supports Cytek Biosciences' market expansion and its commitment to providing advanced cell analysis solutions to research institutions and laboratories.

Ming Yan, the Chief Technology Officer at Cytek Biosciences, spearheads the company's technological innovation and product development. Yan directs the research and development efforts focused on advancing the patented Full Spectrum Profiling technology, which is central to Cytek's advanced cell analysis tools. This leadership position involves overseeing the engineering and scientific teams responsible for creating high-resolution and high-sensitivity cell analysis instruments, including the Aurora and Northern Lights systems. The Chief Technology Officer ensures that the company's technological roadmap aligns with market demands and scientific advancements in the biotechnology sector. Yan's responsibilities extend to the development of supporting software and reagents, enhancing the comprehensive solutions offered to scientific research institutions and laboratories globally. By driving technological excellence, Ming Yan ensures Cytek Biosciences remains at the forefront of cell analysis innovation.

Valerie Barnett, the Chief Legal Officer at Cytek Biosciences, oversees all legal affairs and ensures regulatory compliance across the company's global operations. Barnett manages intellectual property strategy, safeguarding Cytek's patented Full Spectrum Profiling technology and other innovations. This role involves providing legal counsel on corporate governance, contracts, and risk management, supporting the company's business-to-business and business-to-consumer activities. The Chief Legal Officer plays a crucial part in navigating the complex regulatory landscapes in North America, Europe, and Asia, particularly concerning the availability of products like the Northern Lights CLC system for clinical use. Barnett ensures that all business practices adhere to legal standards and ethical guidelines, protecting the company's interests. By managing legal frameworks, Valerie Barnett supports Cytek Biosciences' mission to deliver advanced cell analysis solutions while maintaining operational integrity.

Connie Wedel, the Chief People Officer at Cytek Biosciences, leads human resources strategy and talent management initiatives. Wedel is responsible for cultivating a high-performance culture that supports innovation and growth across the company's global workforce in North America, Europe, and Asia. This role involves overseeing talent acquisition, employee development, compensation, and benefits programs, ensuring Cytek attracts and retains top scientific and technical talent. The Chief People Officer plays a key role in aligning human capital with the company's strategic objectives, particularly in advancing its patented Full Spectrum Profiling technology and developing cutting-edge cell analysis tools. Wedel ensures that employee policies and practices foster an environment conducive to the rigorous research and development required in the biotechnology sector. By focusing on people, Connie Wedel strengthens Cytek Biosciences' capacity to deliver exceptional solutions to scientific research institutions and laboratories.